BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 30530866)

  • 1. Apoptosis and apoptotic body: disease message and therapeutic target potentials.
    Xu X; Lai Y; Hua ZC
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30530866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic bodies: bioactive treasure left behind by the dying cells with robust diagnostic and therapeutic application potentials.
    Yu L; Zhu G; Zhang Z; Yu Y; Zeng L; Xu Z; Weng J; Xia J; Li J; Pathak JL
    J Nanobiotechnology; 2023 Jul; 21(1):218. PubMed ID: 37434199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic Bodies: Mechanism of Formation, Isolation and Functional Relevance.
    Santavanond JP; Rutter SF; Atkin-Smith GK; Poon IKH
    Subcell Biochem; 2021; 97():61-88. PubMed ID: 33779914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the contents and cell origins of apoptotic bodies by flow cytometry.
    Jiang L; Paone S; Caruso S; Atkin-Smith GK; Phan TK; Hulett MD; Poon IKH
    Sci Rep; 2017 Oct; 7(1):14444. PubMed ID: 29089562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy.
    Fu Y; Sui B; Xiang L; Yan X; Wu D; Shi S; Hu X
    Cell Death Dis; 2021 Jun; 12(6):596. PubMed ID: 34108448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the Therapeutic Effects of Apoptotic Bodies on Systemic Diseases.
    Li X; Liu Y; Liu X; Du J; Bhawal UK; Xu J; Guo L; Liu Y
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies.
    Pistritto G; Trisciuoglio D; Ceci C; Garufi A; D'Orazi G
    Aging (Albany NY); 2016 Apr; 8(4):603-19. PubMed ID: 27019364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell proliferation is induced by apoptotic bodies from dying cells during epithelial tissue maintenance.
    Brock CK; Wallin ST; Ruiz OE; Samms KM; Mandal A; Sumner EA; Eisenhoffer GT
    Nat Commun; 2019 Mar; 10(1):1044. PubMed ID: 30837472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and medicinal chemistry approaches towards various apoptosis inducers.
    Vyas VK; Chintha C; Pandya MR
    Anticancer Agents Med Chem; 2013 Mar; 13(3):433-55. PubMed ID: 22721391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic activation of caspases in cancer: a question of selectivity.
    Beauparlant P; Shore GC
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):179-87. PubMed ID: 12669453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disassembly of the Dying: Mechanisms and Functions.
    Atkin-Smith GK; Poon IKH
    Trends Cell Biol; 2017 Feb; 27(2):151-162. PubMed ID: 27647018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and Isolation of Apoptotic Bodies to High Purity.
    Phan TK; Poon IK; Atkin-Smith GK
    J Vis Exp; 2018 Aug; (138):. PubMed ID: 30148494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving beyond size and phosphatidylserine exposure: evidence for a diversity of apoptotic cell-derived extracellular vesicles
    Poon IKH; Parkes MAF; Jiang L; Atkin-Smith GK; Tixeira R; Gregory CD; Ozkocak DC; Rutter SF; Caruso S; Santavanond JP; Paone S; Shi B; Hodge AL; Hulett MD; Chow JDY; Phan TK; Baxter AA
    J Extracell Vesicles; 2019; 8(1):1608786. PubMed ID: 31069027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-apoptotic mechanisms of drug resistance in cancer.
    Wilson TR; Johnston PG; Longley DB
    Curr Cancer Drug Targets; 2009 May; 9(3):307-19. PubMed ID: 19442051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Surface Area to Volume Relationship During Apoptosis and Apoptotic Body Formation.
    López-Hernández FJ
    Cell Physiol Biochem; 2021 May; 55(S1):161-170. PubMed ID: 33961353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gasdermin E Does Not Limit Apoptotic Cell Disassembly by Promoting Early Onset of Secondary Necrosis in Jurkat T Cells and THP-1 Monocytes.
    Tixeira R; Shi B; Parkes MAF; Hodge AL; Caruso S; Hulett MD; Baxter AA; Phan TK; Poon IKH
    Front Immunol; 2018; 9():2842. PubMed ID: 30564238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways.
    Beurel E; Jope RS
    Prog Neurobiol; 2006 Jul; 79(4):173-89. PubMed ID: 16935409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase activity modulators as anticancer agents.
    Okun I; Balakin KV; Tkachenko SE; Ivachtchenko AV
    Anticancer Agents Med Chem; 2008 Apr; 8(3):322-41. PubMed ID: 18393791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic volume decrease as a geometric determinant for cell dismantling into apoptotic bodies.
    Núñez R; Sancho-Martínez SM; Novoa JM; López-Hernández FJ
    Cell Death Differ; 2010 Nov; 17(11):1665-71. PubMed ID: 20706273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of death receptors--relevance in cancer therapies.
    de Thonel A; Eriksson JE
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.